Title: |
HT-Seq profiling of HASMCs treated with NSAIDS and induced with IL-1B
|
Organism(s): |
Homo sapiens
|
Description: |
The goal of this experiment is to identify differences in gene expression in Human Aorta Smooth Muscle cells (HASMCs) treated with the selective and non-selective COX2 inhibitors, celecoxib and naproxen, respectively. HASMCs were treated with various doses of naproxen/celecoxib for 3hrs and then induced with the inflammatory stimuli IL-1B for 0, 2 or 8hrs (extraction time points). At each extraction time point, an aliquot of the media was stored and cells were lysed and stored in TRIZol reagent. The TRIZol reagent was later processed for total RNA extraction.
|
Design(s): |
time series design, compound treatment design, stimulus or stress design, dose response design
|
Experimental factor(s): |
NSAID concentration
13
recorded
|
|
|
0.49 nanomolar
15.63 nanomolar
31.25 nanomolar
62.5 nanomolar
0.98 nanomolar
3.91 nanomolar
7.81 nanomolar
1.95 nanomolar
500 nanomolar
0.24 nanomolar
125 nanomolar
0 nanomolar
0.12 nanomolar
|
IL-1beta exposure
3
recorded
|
|
|
2 hour
0 hour
8 hour
|
NSAID
3
recorded
|
|
|
celecoxib
naproxen
vehicle control condition
|
|
Publication(s): |
|
Sample attribute(s): |
Material Type
2
recorded
|
|
|
primary cell
total RNA
|
sex
1
recorded
|
|
|
male
|
fragment size
20
recorded
|
|
|
281 base pair
291 base pair
282 base pair
279 base pair
289 base pair
305 base pair
287 base pair
303 base pair
301 base pair
284 base pair
278 base pair
273 base pair
274 base pair
271 base pair
286 base pair
292 base pair
295 base pair
269 base pair
272 base pair
297 base pair
|
cell type
1
recorded
|
|
|
aortic smooth muscle cell
|
race
1
recorded
|
|
|
EFO:Caucasian
|
organism
1
recorded
|
|
|
Homo sapiens
|
|
Contact(s): |
Lauren Francey Jacki Growe Anthony Olarerin-George John Hogenesch
|
Release Date: |
|
Submission Date: |
|
Metadata Downloads |
Download Study Metadata as ISAtabDownload Study Metadata as ISAtab
|
Assay Downloads |
transcription profiling using nucleotide sequencing
|
|
60 assays |
|
|
|
|